Received Jul 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
patient was inadvertently administered just the diluent without the powder; the patient received twice the amount of diluent; This non-serious case was reported by a consumer via call center representative and described the occurrence of inappropriate preparation of medication in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On 01-JUL-2025, the patient received Shingrix. On 01-JUL-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: patient was inadvertently administered just the diluent without the powder) and inappropriate dose of vaccine administered (Verbatim: the patient received twice the amount of diluent). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date:01-JUL-2025 This case was reported by a consumer via (Shingrix GSK Chatbot) interactive digital media. A patient was inadvertently administered just the diluent without the powder, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. When the error was identified, the provider than correctly reconstituted the vaccine and administered it. essentially, the patient received twice the amount of diluent. are there any risks or concerned they should look out for. The reporter did not currently have much information, but he/she could reach out to the health center if it was absolutely necessary. The reporter knew it was an unexpired lot and this occurred.